Skip to content

PALATINE

Active
Public limited companyfounded 198739 years activeGérardstraat 150, 1040 Etterbeek, BelgiumKBO/BCE: BE 0430.811.444
Summary

The computed 12-month bankruptcy probability of PALATINE is 2.3% (moderate). The 2025 annual accounts show equity of €487,128 and a net result of -€60,905. Equity is growing by ~7.5% per year across the filed fiscal years. Its solvency ranks better than 18% of 4,935 sector peers (NACE 47, fiscal year 2025). The company has been active since 1987 and the Belgian State Gazette contains no insolvency or warning signals.

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
2 sites
Size
€6.6mtotal assets 2025
Staff
7.4 FTE
Equity
€487,128
Loss
-€60,905
Financial health
51 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
2.3%
Structure
Parent
BLUESTONE · 51.44%
Holdings
4
Accounts filed 22 days late1 of 10 deeds read
Why 51- Liquidity: current ratio 0.28, cash €114,808- Equity €487,128 (7.4% of total assets)- Size: 7.4 FTE, total assets €6.6m- Sector Retail trade (NACE 47)Show the evidence

Checked score

Score 2025
51 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 23% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Weak
Solvency 32-1
equity 7.4% of total assets
Liquidity 20-2
short-term debt 61.7% · cash 1.7%
Profitability 28+3
return on assets -0.9%
Bankruptcy probability, 12 months
2.3% Moderate
0%0.5%1.5%4%10%≥ 25%

About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,169 companies)
Last 24 months 11-2024: 2.4% 12-2024: 2.4%● unchanged vs 11-2024 01-2025: 2.4%● unchanged vs 12-2024 02-2025: 2.4%● unchanged vs 01-2025 03-2025: 2.4%● unchanged vs 02-2025 04-2025: 2.5%▲ +0.1 percentage points vs 03-2025 05-2025: 2.5%● unchanged vs 04-2025 06-2025: 2.5%● unchanged vs 05-2025 07-2025: 2.9%▲ +0.4 percentage points vs 06-2025 08-2025: 3.8%▲ +0.9 percentage points vs 07-2025 09-2025: 2.4%▼ -1.4 percentage points vs 08-2025 10-2025: 2.4%● unchanged vs 09-2025 11-2025: 2.4%● unchanged vs 10-2025 12-2025: 2.4%● unchanged vs 11-2025 01-2026: 2.4%● unchanged vs 12-2025 02-2026: 2.4%● unchanged vs 01-2026 03-2026: 2.4%● unchanged vs 02-2026 04-2026: 2.5%▲ +0.1 percentage points vs 03-2026 05-2026: 2.5%● unchanged vs 04-2026 06-2026: 2.5%● unchanged vs 05-2026 07-2026: 2.5%● unchanged vs 06-2026 08-2026: 3.8%▲ +1.3 percentage points vs 07-2026highest value 09-2026: 2.3%▼ -1.5 percentage points vs 08-2026lowest value 10-2026: 2.3%● unchanged vs 09-2026lowest value
Credit up to €24,000 at 30 days acceptable
Liquidity short (current ratio 0.28 against 0.32 in 2024; short-term debt: 61.7% and cash: 1.7% of total assets), and 92.6% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 24% on solvency, 18% on liquidity, 24% on profitability and 25% on growth.

The bankruptcy probability was computed on 07-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Seven signals.
+raises risk○neutral
raises risk · Liquidity: current ratio 0.28, cash €114,808
NBB · annual accounts
raises risk · Equity €487,128 (7.4% of total assets)
NBB · annual accounts
raises risk · Size: 7.4 FTE, total assets €6.6m
The company's size counts in the probability; how much depends on the rest of its profile.
NBB · annual accounts
raises risk · Sector Retail trade (NACE 47)
KBO
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025
Net result per financial year
1819202122232425
2018 to 2025 · latest year -€60,905
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 18% of 4935 sector peers (2025).
NBB · sector comparison
Position among 4935 sector peers
Solvency
better than 18%
← weakest strongest →
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-08-2026, 22 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
22 days late
2024
21 days late
2023
70 days late
2022
90 days late
2021
75 days late
2020
61 days late
2019
91 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 61 days after the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 10 October (4 of the last 5 filed years within 49 days of that day).
Companies Code · seven months
Position in the running window
08-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Checked from 2021 on.
KBO publications · our coverage
  1. Appointment: Stéphanie THOMAES (director)Permanent representative: Paul RANSART
  2. Annual accounts filedfiscal year 2025 · full…
  3. Annual accounts filedfiscal year 2024 · full…

Key points

  • Caution: Among the weakest 15% on net resultsector median €40,857 · 4,935 companies -€60,905 View
  • Controlled by BLUESTONEitself parent of 6 companies 51.44% View
  • Caution: 2 loss-making years in a rowloss fiscal year 2025 -€60,905 View
  • New directorlatest change 01-01-2026 · 1 in office 1 joined View

By topic

Financials

Fiscal year
2025
Total assets
€6.6m
Loss
-€60,905
Solvency
7.4%
Total assets▼ 3.3%
Net result
20182025
Go to Financials

Timeline

Events
14
Since
2017
Next accounts
by 31-07-2027
  1. 31-12-2024Weakest financial year
  2. 09-10-2024Annual accounts filed
  3. 29-10-2023Annual accounts filed
Go to Timeline

Company details

Sites
2
Legal form
Public limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
25-03-1987
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.